Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology

    February 2018 in “ Genetics research international
    Roshan Dadachanji, Nuzhat F. Shaikh, Srabani Mukherjee
    Image
    Studysummary This review summarizes the influence of gene polymorphisms on genetic predisposition to polycystic ovary syndrome, but reports no new experimental or clinical results.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document reviewed the genetic variants associated with hyperandrogenemia in PCOS, a complex endocrine disorder. It discussed the role of prenatal androgen exposure and reviewed several genes like CYP11A1, CYP17, CYP19, and AR, which are involved in androgen synthesis and action. While some polymorphisms were associated with PCOS risk, such as the CYP11A1 gene polymorphism in Caucasian populations, others like the CYP17 gene polymorphism showed inconsistent associations. The document also examined AR gene's CAG repeat length and SHBG gene polymorphisms, noting their complex associations with PCOS. It highlighted the need for further research, including GWAS, to fully understand the genetic basis of PCOS and improve therapeutic strategies.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results